Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Shake Shack Offering Holiday Freebies
Shake Shack is giving out free fried chicken sandwiches, bacon cheese fries and milkshakes nationwide.
IRS Announces 'Voluntary Disclosure Program'
The IRS is announcing a voluntary disclosure program.
Lionsgate Signs $4.6 Billion Studio SPAC Deal
Lionsgate announced its studio division is going to spin off in a merger with Screaming Eagle Acquisition Corp., which is a special purpose acquisition company.
Redfin: 15.5% of Homes for Sale in 2023 Were Affordable
A new report suggests that it's getting more difficult for an average American to afford a home.
FDA Warns of Fake Ozempic Drugs
The Food and Drug Administration warned consumers about a copycat version of the diabetes drug Ozempic.
Report: Tesla Building Battery Factory in China
Tesla is reportedly moving forward with its plan to make energy shortage storage batteries in China.
Wells Fargo Workers in New Mexico Vote to Unionize
Wells Fargo employees at a branch in New Mexico have voted to unionize.
Nike Cuts Full-Year Revenue Outlook and Announces Cost-Cutting Plan
Nike cut its full-year revenue outlook for the fiscal year after reporting lower-than-expected revenue in its latest quarter.
Stocks Rise As Market Looks to Extend Winning Streak Year-End
Stocks climbed after the opening bell as the market looks to extend its winning streak as the year draws to a close.
